Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Chondrosarcoma Metastasis to the Choroid.

Kim JM, Wong AJ, Lu AJ, Pointdujour-Lim R.

Ocul Oncol Pathol. 2019 Jun;5(4):234-237. doi: 10.1159/000494979. Epub 2019 Jan 17.

PMID:
31367583
2.

Development and Evaluation of a Web-Based Resource for Suicidal Thoughts: NowMattersNow.org.

Whiteside U, Richards J, Huh D, Hidalgo R, Nordhauser R, Wong AJ, Zhang X, Luxton DD, Ellsworth M, Lezine D.

J Med Internet Res. 2019 May 2;21(5):e13183. doi: 10.2196/13183.

3.

Generation of regulable EGFRvIII targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma.

Zheng Y, Gao N, Fu YL, Zhang BY, Li XL, Gupta P, Wong AJ, Li TF, Han SY.

Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):59-66. doi: 10.1016/j.bbrc.2018.10.151. Epub 2018 Nov 6.

4.

Machine Learning Applications in Head and Neck Radiation Oncology: Lessons From Open-Source Radiomics Challenges.

Elhalawani H, Lin TA, Volpe S, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai GE, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD.

Front Oncol. 2018 Aug 17;8:294. doi: 10.3389/fonc.2018.00294. eCollection 2018.

5.

Management of placenta percreta in a Jehovah's Witness patient.

Wong AJ, Schlumbrecht M, Huang M.

BMJ Case Rep. 2018 Jun 11;2018. pii: bcr-2018-225260. doi: 10.1136/bcr-2018-225260.

PMID:
29895551
6.

Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow.

Mohamed ASR, Wong AJ, Fuller CD, Kamal M, Gunn GB, Phan J, Morrison WH, Beadle BM, Skinner H, Lai SY, Quinlan-Davidson SR, Belal AM, El-Gowily AG, Frank SJ, Rosenthal DI, Garden AS.

Radiat Oncol. 2017 Aug 15;12(1):129. doi: 10.1186/s13014-017-0868-y.

7.

Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy.

Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS.

Oral Oncol. 2017 Sep;72:90-97. doi: 10.1016/j.oraloncology.2017.07.002. Epub 2017 Jul 16.

8.

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.

Abdolahpour S, Toliyat T, Omidfar K, Modjtahedi H, Wong AJ, Rasaee MJ, Kashanian S, Paknejad M.

Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):89-94. doi: 10.1080/21691401.2017.1296847. Epub 2017 Mar 15.

PMID:
28296511
9.

Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.

Cardenas CE, Mohamed ASR, Tao R, Wong AJR, Awan MJ, Kuruvila S, Aristophanous M, Gunn GB, Phan J, Beadle BM, Frank SJ, Garden AS, Morrison WH, Fuller CD, Rosenthal DI.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):532-540. doi: 10.1016/j.ijrobp.2016.11.019. Epub 2016 Nov 19.

10.

"Breastfeeding" but not at the breast: Mothers' descriptions of providing pumped human milk to their infants via other containers and caregivers.

Felice JP, Geraghty SR, Quaglieri CW, Yamada R, Wong AJ, Rasmussen KM.

Matern Child Nutr. 2017 Jul;13(3). doi: 10.1111/mcn.12425. Epub 2017 Jan 12.

11.

"Breastfeeding" without baby: A longitudinal, qualitative investigation of how mothers perceive, feel about, and practice human milk expression.

Felice JP, Geraghty SR, Quaglieri CW, Yamada R, Wong AJ, Rasmussen KM.

Matern Child Nutr. 2017 Jul;13(3). doi: 10.1111/mcn.12426. Epub 2017 Jan 12.

12.

Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm.

Chang M, Wong AJ, Raugi DN, Smith RA, Seilie AM, Ortega JP, Bogusz KM, Sall F, Ba S, Seydi M, Gottlieb GS, Coombs RW.

J Clin Virol. 2017 Jan;86:56-61. doi: 10.1016/j.jcv.2016.11.011. Epub 2016 Nov 23.

13.

Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.

Blanchard P, Wong AJ, Gunn GB, Garden AS, Mohamed ASR, Rosenthal DI, Crutison J, Wu R, Zhang X, Zhu XR, Mohan R, Amin MV, Fuller CD, Frank SJ.

Radiother Oncol. 2016 Dec;121(3):381-386. doi: 10.1016/j.radonc.2016.08.022. Epub 2016 Sep 15.

14.

Radiomics in head and neck cancer: from exploration to application.

Wong AJ, Kanwar A, Mohamed AS, Fuller CD.

Transl Cancer Res. 2016 Aug;5(4):371-382. doi: 10.21037/tcr.2016.07.18.

15.

DNA Sequence-Specific Binding of CENP-B Enhances the Fidelity of Human Centromere Function.

Fachinetti D, Han JS, McMahon MA, Ly P, Abdullah A, Wong AJ, Cleveland DW.

Dev Cell. 2015 May 4;33(3):314-27. doi: 10.1016/j.devcel.2015.03.020.

16.

IgG4 immunostaining and its implications in orbital inflammatory disease.

Wong AJ, Planck SR, Choi D, Harrington CA, Troxell ML, Houghton DC, Stauffer P, Wilson DJ, Grossniklaus HE, Dailey RA, Ng JD, Steele EA, Harris GJ, Czyz C, Foster JA, White VA, Dolman PJ, Kazim M, Patel PJ, Edward DP, al Katan H, al Hussain H, Selva D, Yeatts RP, Korn BS, Kikkawa DO, Rosenbaum JT.

PLoS One. 2014 Oct 10;9(10):e109847. doi: 10.1371/journal.pone.0109847. eCollection 2014.

17.

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.

Emlet DR, Gupta P, Holgado-Madruga M, Del Vecchio CA, Mitra SS, Han SY, Li G, Jensen KC, Vogel H, Xu LW, Skirboll SS, Wong AJ.

Cancer Res. 2014 Feb 15;74(4):1238-49. doi: 10.1158/0008-5472.CAN-13-1407. Epub 2013 Dec 23.

18.

A two-step mechanism for epigenetic specification of centromere identity and function.

Fachinetti D, Folco HD, Nechemia-Arbely Y, Valente LP, Nguyen K, Wong AJ, Zhu Q, Holland AJ, Desai A, Jansen LE, Cleveland DW.

Nat Cell Biol. 2013 Sep;15(9):1056-66. doi: 10.1038/ncb2805. Epub 2013 Jul 21.

19.

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma.

Shen CJ, Yang YX, Han EQ, Cao N, Wang YF, Wang Y, Zhao YY, Zhao LM, Cui J, Gupta P, Wong AJ, Han SY.

J Hematol Oncol. 2013 May 9;6:33. doi: 10.1186/1756-8722-6-33.

20.

Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.

Giacomini CP, Sun S, Varma S, Shain AH, Giacomini MM, Balagtas J, Sweeney RT, Lai E, Del Vecchio CA, Forster AD, Clarke N, Montgomery KD, Zhu S, Wong AJ, van de Rijn M, West RB, Pollack JR.

PLoS Genet. 2013 Apr;9(4):e1003464. doi: 10.1371/journal.pgen.1003464. Epub 2013 Apr 25.

21.

EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.

Del Vecchio CA, Giacomini CP, Vogel H, Jensen KC, Florio T, Merlo A, Pollack JR, Wong AJ.

Oncogene. 2013 May 23;32(21):2670-81. doi: 10.1038/onc.2012.280. Epub 2012 Jul 16.

PMID:
22797070
22.

Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma.

Del Vecchio CA, Jensen KC, Nitta RT, Shain AH, Giacomini CP, Wong AJ.

Cancer Res. 2012 May 15;72(10):2657-71. doi: 10.1158/0008-5472.CAN-11-2656. Epub 2012 Mar 14.

23.

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.

Li G, Mitra SS, Monje M, Henrich KN, Bangs CD, Nitta RT, Wong AJ.

J Neurooncol. 2012 Jul;108(3):395-402. doi: 10.1007/s11060-012-0842-3. Epub 2012 Mar 2.

24.

Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10.

Modjtahedi H, Khelwatty SA, Kirk RS, Seddon AM, Essapen S, Del Vecchio CA, Wong AJ, Eccles S.

Br J Cancer. 2012 Feb 28;106(5):883-8. doi: 10.1038/bjc.2012.27. Epub 2012 Feb 7.

25.

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.

Del Vecchio CA, Li G, Wong AJ.

Expert Rev Vaccines. 2012 Feb;11(2):133-44. doi: 10.1586/erv.11.177. Review.

PMID:
22309662
26.

A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors.

Piccione EC, Lieu TJ, Gentile CF, Williams TR, Connolly AJ, Godwin AK, Koong AC, Wong AJ.

Oncogene. 2012 Jun 14;31(24):2953-67. doi: 10.1038/onc.2011.465. Epub 2011 Oct 10.

27.

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma.

Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, Attema JL, Li G, Haddix T, Edwards MS, Fisher PG, Weissman IL, Rowitch DH, Vogel H, Wong AJ, Beachy PA.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4453-8. doi: 10.1073/pnas.1101657108. Epub 2011 Mar 1.

28.
29.

Measuring the constitutive activation of c-Jun N-terminal kinase isoforms.

Nitta RT, Badal SS, Wong AJ.

Methods Enzymol. 2010;484:531-48. doi: 10.1016/B978-0-12-381298-8.00026-5.

30.

Development of an EGFRvIII specific recombinant antibody.

Gupta P, Han SY, Holgado-Madruga M, Mitra SS, Li G, Nitta RT, Wong AJ.

BMC Biotechnol. 2010 Oct 7;10:72. doi: 10.1186/1472-6750-10-72.

31.

The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis.

Nitta RT, Del Vecchio CA, Chu AH, Mitra SS, Godwin AK, Wong AJ.

Oncogene. 2011 Jan 13;30(2):234-44. doi: 10.1038/onc.2010.414. Epub 2010 Sep 27.

32.

Synthesis of aminooxy and N-alkylaminooxy amines for use in bioconjugation.

Carrasco MR, Alvarado CI, Dashner ST, Wong AJ, Wong MA.

J Org Chem. 2010 Aug 20;75(16):5757-9. doi: 10.1021/jo101066c.

PMID:
20704452
33.

A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.

Segev A, Nili N, Osherov AB, Qiang B, Wong AJ, Pillarisetti S, Strauss BH.

EuroIntervention. 2010 May;6(1):134-40. doi: 10.4244/.

PMID:
20542809
34.

Pineal parenchymal tumor of intermediate differentiation: clinicopathological report and analysis of epidermal growth factor receptor variant III expression.

Li G, Mitra S, Karamchandani J, Edwards MS, Wong AJ.

Neurosurgery. 2010 May;66(5):963-8; discussion 968. doi: 10.1227/01.NEU.0000367726.49003.F1.

PMID:
20404701
35.

The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas.

Li G, Mitra S, Wong AJ.

Neurosurg Clin N Am. 2010 Jan;21(1):87-93. doi: 10.1016/j.nec.2009.08.004. Review.

PMID:
19944969
36.

Chemoselective and microwave-assisted synthesis of glycopeptoids.

Seo J, Michaelian N, Owens SC, Dashner ST, Wong AJ, Barron AE, Carrasco MR.

Org Lett. 2009 Nov 19;11(22):5210-3. doi: 10.1021/ol9021468.

PMID:
19905028
37.

Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation.

Nitta RT, Chu AH, Wong AJ.

J Biol Chem. 2008 Dec 12;283(50):34935-45. doi: 10.1074/jbc.M804970200. Epub 2008 Oct 21.

38.

EGF receptor variant III as a target antigen for tumor immunotherapy.

Li G, Wong AJ.

Expert Rev Vaccines. 2008 Sep;7(7):977-85. doi: 10.1586/14760584.7.7.977. Review.

PMID:
18767947
39.

A variant epidermal growth factor receptor protein is similarly expressed in benign hyperplastic and carcinomatous prostatic tissues in black and white men.

Olapade-Olaopa EO, Moscatello DK, MacKay EH, Ogunbiyi JO, Shittu OB, Terry TR, Okeke LI, Wong AJ, Habib FK.

West Afr J Med. 2007 Jan-Mar;26(1):42-7.

PMID:
17595991
40.

The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation.

Laramée M, Chabot C, Cloutier M, Stenne R, Holgado-Madruga M, Wong AJ, Royal I.

J Biol Chem. 2007 Mar 16;282(11):7758-69. Epub 2006 Dec 17.

41.

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.

Cui J, Han SY, Wang C, Su W, Harshyne L, Holgado-Madruga M, Wong AJ.

Cancer Res. 2006 Oct 15;66(20):10024-31.

42.

A new phylogenetic lineage of rabies virus associated with western pipistrelle bats (Pipistrellus hesperus).

Franka R, Constantine DG, Kuzmin I, Velasco-Villa A, Reeder SA, Streicker D, Orciari LA, Wong AJ, Blanton JD, Rupprecht CE.

J Gen Virol. 2006 Aug;87(Pt 8):2309-21.

PMID:
16847127
43.

Beta1 integrins modulate cell adhesion by regulating insulin-like growth factor-II levels in the microenvironment.

Goel HL, Moro L, King M, Teider N, Centrella M, McCarthy TL, Holgado-Madruga M, Wong AJ, Marra E, Languino LR.

Cancer Res. 2006 Jan 1;66(1):331-42.

44.

Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.

Olapade-Olaopa EO, Moscatello DK, MacKay EH, Sandhu DP, Terry TR, Wong AJ, Habib FK.

Afr J Med Med Sci. 2004 Sep;33(3):245-53.

PMID:
15819472
45.

Identification of a specific domain responsible for JNK2alpha2 autophosphorylation.

Cui J, Holgado-Madruga M, Su W, Tsuiki H, Wedegaertner P, Wong AJ.

J Biol Chem. 2005 Mar 18;280(11):9913-20. Epub 2005 Jan 6.

46.

Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.

Holgado-Madruga M, Wong AJ.

Cancer Res. 2004 Mar 15;64(6):2007-15.

47.

A novel technique to eliminate cross-contamination when making wells on slides for rabies diagnosis.

Wong AJ, Constantine DG, Armstrong O, Wong WY, Comb JC.

J Virol Methods. 2004 Feb;115(2):117-22.

PMID:
14667527
48.

Gab1 is an integrator of cell death versus cell survival signals in oxidative stress.

Holgado-Madruga M, Wong AJ.

Mol Cell Biol. 2003 Jul;23(13):4471-84.

49.

Expression of constitutively activated EGFRvIII in non-small cell lung cancer.

Okamoto I, Kenyon LC, Emlet DR, Mori T, Sasaki J, Hirosako S, Ichikawa Y, Kishi H, Godwin AK, Yoshioka M, Suga M, Matsumoto M, Wong AJ.

Cancer Sci. 2003 Jan;94(1):50-6.

50.

Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.

Modjtahedi H, Moscatello DK, Box G, Green M, Shotton C, Lamb DJ, Reynolds LJ, Wong AJ, Dean C, Thomas H, Eccles S.

Int J Cancer. 2003 Jun 10;105(2):273-80.

Supplemental Content

Support Center